|
1
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang C, Hecht EM, Soloff EV, Tiwari HA,
Bhosale PR, Dasayam A, Galgano SJ, Kambadakone A, Kulkarni NM, Le
O, et al: Imaging for early detection of pancreatic ductal
adenocarcinoma: Updates and challenges in the implementation of
screening and surveillance programs. AJR Am J Roentgenol.
223:e24311512024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blackford AL, Canto MI, Klein AP, Hruban
RH and Goggins M: Recent trends in the incidence and survival of
stage 1A pancreatic cancer: A surveillance, epidemiology, and end
results analysis. J Natl Cancer Inst. 112:1162–1169. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haberle L, Schramm M and Esposito I:
Preoperative diagnostics of pancreatic neoplasms. Pathologe.
42:491–500. 2021.(In German). PubMed/NCBI
|
|
5
|
Bararia A, Chakraborty P, Roy P,
Chattopadhay BK, Das A, Chatterjee A and Sikdar N: Emerging role of
non-invasive and liquid biopsy biomarkers in pancreatic cancer.
World J Gastroenterol. 29:2241–2260. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schorr F and Essig MW: Early detection of
pancreatic cancer - The role of endoscopic and transabdominal
ultrasound. Z Gastroenterol. 59:1083–1090. 2021.(In German).
PubMed/NCBI
|
|
7
|
Koziol-Bohatkiewicz P, Liberda-Matyja D
and Wrobel TP: Fast cancer imaging in pancreatic biopsies using
infrared imaging. Analyst. 149:1799–1806. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zofia Rogowska A: Ultrasound-guided
percutaneous core-needle biopsy of focal pancreatic
lesions-practical aspectss. J Ultrason. 22:117–120. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takahashi K, Takeda Y, Ono Y, Isomoto H
and Mizukami Y: Current status of molecular diagnostic approaches
using liquid biopsy. J Gastroenterol. 58:834–847. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang J, Xu R, Wang C, Qiu J, Ren B and You
L: Early screening and diagnosis strategies of pancreatic cancer: A
comprehensive review. Cancer Commun (Lond). 41:1257–1274. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Inchingolo R, Acquafredda F, Posa A, Nunes
TF, Spiliopoulos S, Panzera F and Praticò CA: Endobiliary biopsy.
World J Gastrointest Endosc. 14:291–301. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Navaneethan U, Spencer C, Zhu X, Vargo JJ,
Grove D and Dweik RA: Volatile organic compounds in bile can
distinguish pancreatic cancer from chronic pancreatitis: A
prospective observational study. Endoscopy. 53:732–736. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martinez-Moral MP, Tena MT,
Martin-Carnicero A and Martinez A: Highly sensitive serum
volatolomic biomarkers for pancreatic cancer diagnosis. Clin Chim
Acta. 557:1178952024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Daulton E, Wicaksono AN, Tiele A, Kocher
HM, Debernardi S, Crnogorac-Jurcevic T and Covington JA: Volatile
organic compounds (VOCs) for the non-invasive detection of
pancreatic cancer from urine. Talanta. 221:1216042021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma X, He C, Wang Y, Cao X, Jin Z, Ge Y,
Cao Z, An M and Hao L: Mechanisms and applications of
manganese-based nanomaterials in tumor diagnosis and therapy.
Biomater Res. 29:01582025. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu X, Wang Z, Zhu Y, Li Z, Yan H, Zhao X
and Wang Q: Advancements in molecular imaging for the diagnosis and
treatment of pancreatic ductal adenocarcinoma. Nanoscale Adv. Apr
22–2025.(Epub ahead of print). View Article : Google Scholar
|
|
17
|
Sijithra PC, Santhi N and Ramasamy N: A
review study on early detection of pancreatic ductal adenocarcinoma
using artificial intelligence assisted diagnostic methods. Eur J
Radiol. 166:1109722023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakahodo J, Kikuyama M, Nojiri S, Chiba K,
Yoshimoto K, Kamisawa T, Horiguchi SI and Honda G: Focal
parenchymal atrophy of pancreas: An important sign of underlying
high-grade pancreatic intraepithelial neoplasia without invasive
carcinoma, i.e., carcinoma in situ. Pancreatology. 20:1689–1697.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamao K, Takenaka M, Ishikawa R, Okamoto
A, Yamazaki T, Nakai A, Omoto S, Kamata K, Minaga K, Matsumoto I,
et al: Partial pancreatic parenchymal atrophy is a new specific
finding to diagnose small pancreatic cancer (</=10 mm) including
carcinoma in situ: Comparison with localized benign main pancreatic
duct stenosis patients. Diagnostics (Basel). 10:4452020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanno A, Masamune A, Hanada K, Maguchi H,
Shimizu Y, Ueki T, Hasebe O, Ohtsuka T, Nakamura M, Takenaka M, et
al: Multicenter study of early pancreatic cancer in Japan.
Pancreatology. 18:61–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kono Y, Oishi T, Ueda Y, Matsuoka E,
Kamimura R, Tokiyoshi T, Okamoto T and Kashima S: A surgically
resected case of lung metastases and sister Mary Joseph's Nodule 24
months after operation for pancreatic cancer. Gan To Kagaku Ryoho.
46:2354–2356. 2019.(In Japanese). PubMed/NCBI
|
|
22
|
Jia WY, Gui Y, Chen XQ, Tan L, Zhang J,
Xiao MS, Chang XY, Dai MH, Guo JC, Cheng YJ, et al: Efficacy of
color Doppler ultrasound and contrast-enhanced ultrasound in
identifying vascular invasion in pancreatic ductal adenocarcinoma.
Insights Imaging. 15:1812024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bonde A, Smith DA, Kikano E, Yoest JM,
Tirumani SH and Ramaiya NH: Overview of serum and tissue markers in
colorectal cancer: A primer for radiologists. Abdom Radiol (NY).
46:5521–5535. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou D, Mu D, Cheng M, Dou Y, Zhang X,
Feng Z, Qiu G, Yu H, Chen Y, Xu H, et al: Differences in lipidomics
may be potential biomarkers for early diagnosis of pancreatic
cancer. Acta Cir Bras. 35:e2020005082020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boyd LNC, Ali M, Comandatore A, Garajova
I, Kam L, Puik JR, Fraga Rodrigues SM, Meijer LL, Le Large TYS,
Besselink MG, et al: Prediction model for early-stage pancreatic
cancer using routinely measured blood biomarkers. JAMA Netw Open.
6:e23311972023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo W, Ying P, Ma R, Jing Z, Ma G, Long J,
Li G and Liu Z: Liquid biopsy analysis of lipometabolic exosomes in
pancreatic cancer. Cytokine Growth Factor Rev. 73:69–77. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dahiya DS, Shah YR, Ali H, Chandan S,
Gangwani MK, Canakis A, Ramai D, Hayat U, Pinnam BSM, Iqbal A, et
al: Basic principles and role of endoscopic ultrasound in diagnosis
and differentiation of pancreatic cancer from other pancreatic
lesions: A comprehensive review of endoscopic ultrasound for
pancreatic cancer. J Clin Med. 13:25992024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park JM, Mau CZ, Chen YC, Su YH, Chen HA,
Huang SY, Chang JS and Chiu CF: A case-control study in Taiwanese
cohort and meta-analysis of serum ferritin in pancreatic cancer.
Sci Rep. 11:212422021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dias ESD and Chung V: Neoadjuvant
treatment for pancreatic cancer: Controversies and advances. Cancer
Treat Res Commun. 39:1008042024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roehnisch T, Martos-Contreras MC,
Manoochehri M, Nogueira M, Bremm F, Dörrie J, Christoph J, Kunz M
and Schönharting W: Individualized neoantigen peptide immunization
of a metastatic pancreatic cancer patient: A case report of
combined tumor and liquid biopsy. Front Immunol. 15:14147372024.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singhi AD, Koay EJ, Chari ST and Maitra A:
Early detection of pancreatic cancer: Opportunities and challenges.
Gastroenterology. 156:2024–2040. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ishikawa-Kakiya Y, Maruyama H, Kinoshita
Y, Hayashi K, Yamamura M, Tanoue K, Nagami Y, Tanigawa T, Watanabe
T and Fujiwara Y: The usefulness of serial pancreatic juice
aspiration cytological examination for pancreatic cancer not
diagnosed by EUS-FNAB. Clin J Gastroenterol. 13:1367–1372. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chalfant H, Bonds M, Scott K, Condacse A,
Dennahy IS, Martin WT, Little C, Edil BH, McNally LR and Jain A:
Innovative imaging techniques used to evaluate
borderline-resectable pancreatic adenocarcinoma. J Surg Res.
284:42–53. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tantau A, Leucuta DC, Tantau M, Boţan E,
Zaharie R, Mândruţiu A and Tomuleasa IC: Inflammation, tumoral
markers and interleukin-17, −10, and −6 profiles in pancreatic
adenocarcinoma and chronic pancreatitis. Dig Dis Sci. 66:3427–3438.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wiest NE, Moktan VP, Oman SP and Chirila
RM: Screening for pancreatic cancer: A review for general
clinicians. Rom J Intern Med. 58:119–128. 2020.PubMed/NCBI
|
|
36
|
Granata V, Fusco R, Setola SV, Galdiero R,
Maggialetti N, Silvestro L, De Bellis M, Di Girolamo E, Grazzini G,
Chiti G, et al: Risk assessment and pancreatic cancer: Diagnostic
management and artificial intelligence. Cancers (Basel).
15:3512023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chu LC and Fishman EK: Pancreatic ductal
adenocarcinoma staging: A narrative review of radiologic techniques
and advances. Int J Surg. 110:6052–6063. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koh DM, Papanikolaou N, Bick U, Illing R,
Kahn CE Jr, Kalpathi-Cramer J, Matos C, Martí-Bonmatí L, Miles A,
Mun SK, et al: Artificial intelligence and machine learning in
cancer imaging. Commun Med (Lond). 2:1332022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mukund A, Afridi MA, Karolak A, Park MA,
Permuth JB and Rasool G: Pancreatic ductal adenocarcinoma (PDAC): A
review of recent advancements enabled by artificial intelligence.
Cancers (Basel). 16:22402024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Udristoiu AL, Cazacu IM, Gruionu LG,
Gruionu G, Iacob AV, Burtea DE, Ungureanu BS, Costache MI,
Constantin A, Popescu CF, et al: Real-time computer-aided diagnosis
of focal pancreatic masses from endoscopic ultrasound imaging based
on a hybrid convolutional and long short-term memory neural network
model. PLoS One. 16:e02517012021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tong T, Gu J, Xu D, Song L, Zhao Q, Cheng
F, Yuan Z, Tian S, Yang X, Tian J, et al: Deep learning radiomics
based on contrast-enhanced ultrasound images for assisted diagnosis
of pancreatic ductal adenocarcinoma and chronic pancreatitis. BMC
Med. 20:742022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tonozuka R, Itoi T, Nagata N, Kojima H,
Sofuni A, Tsuchiya T, Ishii K, Tanaka R, Nagakawa Y and Mukai S:
Deep learning analysis for the detection of pancreatic cancer on
endosonographic images: A pilot study. J Hepatobiliary Pancreat
Sci. 28:95–104. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Marya NB, Powers PD, Chari ST, Gleeson FC,
Leggett CL, Abu Dayyeh BK, Chandrasekhara V, Iyer PG, Majumder S,
Pearson RK, et al: Utilisation of artificial intelligence for the
development of an EUS-convolutional neural network model trained to
enhance the diagnosis of autoimmune pancreatitis. Gut.
70:1335–1344. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kuwahara T, Hara K, Mizuno N, Haba S,
Okuno N, Kuraishi Y, Fumihara D, Yanaidani T, Ishikawa S, Yasuda T,
et al: Artificial intelligence using deep learning analysis of
endoscopic ultrasonography images for the differential diagnosis of
pancreatic masses. Endoscopy. 55:140–149. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma H, Liu ZX, Zhang JJ, Wu FT, Xu CF, Shen
Z, Yu CH and Li YM: Construction of a convolutional neural network
classifier developed by computed tomography images for pancreatic
cancer diagnosis. World J Gastroenterol. 26:5156–5168. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu SL, Li S, Guo YT, Zhou YP, Zhang ZD,
Li S and Lu Y: Establishment and application of an artificial
intelligence diagnosis system for pancreatic cancer with a faster
region-based convolutional neural network. Chin Med J (Engl).
132:2795–2803. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Si K, Xue Y, Yu X, Zhu X, Li Q, Gong W,
Liang T and Duan S: Fully end-to-end deep-learning-based diagnosis
of pancreatic tumors. Theranostics. 11:1982–1990. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Qiu JJ, Yin J, Qian W, Liu JH, Huang ZX,
Yu HP, Ji L and Zeng XX: A novel multiresolution-statistical
texture analysis architecture: Radiomics-aided diagnosis of PDAC
based on plain CT images. IEEE Trans Med Imaging. 40:12–25. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qureshi TA, Gaddam S, Wachsman AM, Wang L,
Azab L, Asadpour V, Chen W, Xie Y, Wu B, Pandol SJ and Li D:
Predicting pancreatic ductal adenocarcinoma using artificial
intelligence analysis of pre-diagnostic computed tomography images.
Cancer Biomark. 33:211–217. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ebrahimian S, Singh R, Netaji A,
Madhusudhan KS, Homayounieh F, Primak A, Lades F, Saini S, Kalra MK
and Sharma S: Characterization of benign and malignant pancreatic
lesions with DECT quantitative metrics and radiomics. Acad Radiol.
29:705–713. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chu LC, Park S, Kawamoto S, Fouladi DF,
Shayesteh S, Zinreich ES, Graves JS, Horton KM, Hruban RH, Yuille
AL, et al: Utility of CT radiomics features in differentiation of
pancreatic ductal adenocarcinoma from normal pancreatic tissue. AJR
Am J Roentgenol. 213:349–357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mukherjee S, Patra A, Khasawneh H,
Korfiatis P, Rajamohan N, Suman G, Majumder S, Panda A, Johnson MP,
Larson NB, et al: Radiomics-based machine-learning models can
detect pancreatic cancer on prediagnostic computed tomography scans
at a substantial lead time before clinical diagnosis.
Gastroenterology. 163:1435–1446. e32022. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li J, Liu F, Fang X, Cao K, Meng Y, Zhang
H, Yu J, Feng X, Li Q, Liu Y, et al: CT radiomics features in
differentiation of focal-type autoimmune pancreatitis from
pancreatic ductal adenocarcinoma: A propensity score analysis. Acad
Radiol. 29:358–366. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ziegelmayer S, Kaissis G, Harder F,
Jungmann F, Müller T, Makowski M and Braren R: Deep convolutional
neural network-assisted feature extraction for diagnostic
discrimination and feature visualization in pancreatic ductal
adenocarcinoma (PDAC) versus autoimmune pancreatitis (AIP). J Clin
Med. 9:40132020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cao K, Xia Y, Yao J, Han X, Lambert L,
Zhang T, Tang W, Jin G, Jiang H, Fang X, et al: Large-scale
pancreatic cancer detection via non-contrast CT and deep learning.
Nat Med. 29:3033–3043. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen PT, Wu T, Wang P, Chang D, Liu KL, Wu
MS, Roth HR, Lee PC, Liao WC and Wang W: pancreatic cancer
detection on ct scans with deep learning: A nationwide
population-based study. Radiology. 306:172–182. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Tayebi Arasteh S, Ziller A, Kuhl C,
Makowski M, Nebelung S, Braren R, Rueckert D, Truhn D and Kaissis
G: Preserving fairness and diagnostic accuracy in private
large-scale AI models for medical imaging. Commun Med (Lond).
4:462024. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liang Y, Schott D, Zhang Y, Wang Z, Nasief
H, Paulson E, Hall W, Knechtges P, Erickson B and Li XA:
Auto-segmentation of pancreatic tumor in multi-parametric MRI using
deep convolutional neural networks. Radiother Oncol. 145:193–200.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li J, Feng C, Lin X and Qian X: Utilizing
GCN and meta-learning strategy in unsupervised domain adaptation
for pancreatic cancer segmentation. IEEE J Biomed Health Inform.
26:79–89. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen X, Chen Z, Li J, Zhang YD, Lin X and
Qian X: Model-driven deep learning method for pancreatic cancer
segmentation based on spiral-transformation. IEEE Trans Med
Imaging. 41:75–87. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li S, Jiang H, Wang Z, Zhang G and Yao YD:
An effective computer aided diagnosis model for pancreas cancer on
PET/CT images. Comput Methods Programs Biomed. 165:205–214. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu Z, Li M, Zuo C, Yang Z and Yang X, Ren
S, Peng Y, Sun G, Shen J, Cheng C and Yang X: Radiomics model of
dual-time 2-[(18)F]FDG PET/CT imaging to distinguish between
pancreatic ductal adenocarcinoma and autoimmune pancreatitis. Eur
Radiol. 31:6983–6991. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhang Y, Cheng C, Liu Z, Wang L, Pan G,
Sun G, Chang Y, Zuo C and Yang X: Radiomics analysis for the
differentiation of autoimmune pancreatitis and pancreatic ductal
adenocarcinoma in (18) F-FDG PET/CT. Med Phys. 46:4520–4530. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yu H, Zhang C, Liu S, Jiang G, Li S, Zhang
L, Wang Y and Xu W: Clinical value of CT-guided percutaneous
fine-needle aspiration biopsy for peritoneal lesions. BMC Med
Imaging. 20:1222020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lee JH, Kim H, Lee SH, Ku JL, Chun JW, Seo
HY, Kim SC, Paik WH, Ryu JK, Lee SK, et al: Establishment of
patient-derived pancreatic cancer organoids from endoscopic
ultrasound-guided fine-needle aspiration biopsies. Gut Liver.
16:625–636. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Masuda H, Kotecha K, Maitra R, Gill AJ,
Mittal A and Samra JS: Clinical suspicion of pancreatic cancer
despite negative endoscopic ultrasound-guided fine-needle
aspiration biopsy. ANZ J Surg. 92:99–108. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Abe I and Lam AK: Fine-needle aspiration
under guidance of ultrasound examination of thyroid lesions.
Methods Mol Biol. 2534:29–37. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Smetanina SV, Slavnova EN, Smetanina OV,
Golovin ST and Eremin NV: Features of differential cytological
diagnosis of primary and metastatic liver carcinoma. Klin Lab
Diagn. 66:364–370. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Taniuchi K, Ueno M, Yokose T, Sakaguchi M,
Yoshioka R, Ogasawara M, Kosaki T, Naganuma S and Furihata M:
Upregulation of PODXL and ITGB1 in pancreatic cancer tissues
preoperatively obtained by EUS-FNAB correlates with unfavorable
prognosis of postoperative pancreatic cancer patients. PLoS One.
17:e02651722022. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Mason J, Lundberg E, Jonsson P, Nyström H,
Franklin O, Lundin C, Naredi P, Antti H, Sund M and Öhlund D: A
cross-sectional and longitudinal analysis of pre-diagnostic blood
plasma biomarkers for early detection of pancreatic cancer. Int J
Mol Sci. 23:129692022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Pietri E, Balsano R, Coriano M, Gelsomino
F, Leonardi F, Bui S, Gnetti L, Valle RD and Garajová I: The
implication of liquid biopsies to predict chemoresistance in
pancreatic cancer. Cancer Drug Resist. 4:559–572. 2021.PubMed/NCBI
|
|
72
|
Gu YL, Lan C, Pei H, Yang SN, Liu YF and
Xiao LL: Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in
diagnosis and prognosis for patients with pancreatic cancer treated
by concurrent chemoradiotherapy. Asian Pac J Cancer Prev.
16:6569–6573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhang J, Wang Y, Zhao T, Li Y, Tian L,
Zhao J and Zhang J: Evaluation of serum MUC5AC in combination with
CA19-9 for the diagnosis of pancreatic cancer. World J Surg Oncol.
18:312020. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Jahan R, Ganguly K, Smith LM, Atri P,
Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha
MA, et al: Trefoil factor(s) and CA19.9: A promising panel for
early detection of pancreatic cancer. EBioMedicine. 42:375–385.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Aronsson L, Andersson R, Bauden M,
Andersson B, Bygott T and Ansari D: High-density and targeted
glycoproteomic profiling of serum proteins in pancreatic cancer and
intraductal papillary mucinous neoplasm. Scand J Gastroenterol.
53:1597–1603. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Li X, Wang Q and Wang R: Roles of exosome
genomic DNA in colorectal cancer. Front Pharmacol. 13:9232322022.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang ZY, Wang RX, Ding XQ, Zhang X, Pan XR
and Tong JH: A protocol for cancer-related mutation detection on
exosomal DNA in clinical application. Front Oncol. 10:5581062020.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zhu Y, Zhang H, Chen N, Hao J, Jin H and
Ma X: Diagnostic value of various liquid biopsy methods for
pancreatic cancer: A systematic review and meta-analysis. Medicine
(Baltimore). 99:e185812020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhu Z, Zhang Y, Zhang W, Tang D, Zhang S,
Wang L, Zou X, Ni Z, Zhang S, Lv Y and Xiang N: High-throughput
enrichment of portal venous circulating tumor cells for highly
sensitive diagnosis of CA19-9-negative pancreatic cancer patients
using inertial microfluidics. Biosens Bioelectron. 259:1164112024.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Chen M, Liu H, Xiao Y, Liang R, Xu H, Hong
B and Qian Y: Predictive biomarkers of pancreatic cancer
metastasis: A comprehensive review. Clin Chim Acta. 569:1201762025.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Luo K, Wang X, Zhang X, Liu Z, Huang S and
Li R: The value of circulating tumor cells in the prognosis and
treatment of pancreatic cancer. Front Oncol. 12:9336452022.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Cui Y and Cao M: Liquid biopsy in bladder
cancer. Methods Mol Biol. 2695:111–120. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Nagai M, Sho M, Akahori T, Nakagawa K and
Nakamura K: Application of liquid biopsy for surgical management of
pancreatic cancer. Ann Gastroenterol Surg. 4:216–223. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gu X, Wei S and Lv X: Circulating tumor
cells: From new biological insights to clinical practice. Signal
Transduct Target Ther. 9:2262024. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Antonarakis ES, Lu C, Luber B, Wang H,
Chen Y, Zhu Y, Silberstein JL, Taylor MN, Maughan BL, Denmeade SR,
et al: Clinical significance of androgen receptor splice variant-7
mRNA detection in circulating tumor cells of men with metastatic
castration-resistant prostate cancer treated with first- and
second-line abiraterone and enzalutamide. J Clin Oncol.
35:2149–2156. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Silva ATF, Rodrigues CM, Ferreira ICC,
Santos LLD, Santos DW, Araújo TG, Canto PPL, Paiva CE, Goulart LR
and Maia YCP: A novel detection method of breast cancer through a
simple panel of biomarkers. Int J Mol Sci. 23:119832022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Earl J, Garcia-Nieto S, Martinez-Avila JC,
Montans J, Sanjuanbenito A, Rodríguez-Garrote M, Lisa E, Mendía E,
Lobo E, Malats N, et al: Circulating tumor cells (Ctc) and kras
mutant circulating free Dna (cfdna) detection in peripheral blood
as biomarkers in patients diagnosed with exocrine pancreatic
cancer. BMC Cancer. 15:7972015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhang ZH, Bao YW, Zhao YJ, Wang JQ, Guo JT
and Sun SY: Circulating tumor cells as potential prognostic
biomarkers for early-stage pancreatic cancer: A systematic review
and meta-analysis. World J Clin Oncol. 14:504–517. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ankeny JS, Court CM, Hou S, Li Q, Song M,
Wu D, Chen JF, Lee T, Lin M, Sho S, et al: Circulating tumour cells
as a biomarker for diagnosis and staging in pancreatic cancer. Br J
Cancer. 114:1367–1375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Bidard FC, Huguet F, Louvet C, Mineur L,
Bouché O, Chibaudel B, Artru P, Desseigne F, Bachet JB, Mathiot C,
et al: Circulating tumor cells in locally advanced pancreatic
adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial.
Ann Oncol. 24:2057–2061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Tien YW, Kuo HC, Ho BI, Chang MC, Chang
YT, Cheng MF, Chen HL, Liang TY, Wang CF, Huang CY, et al: A high
circulating tumor cell count in portal vein predicts liver
metastasis from periampullary or pancreatic cancer: A high portal
venous CTC count predicts liver metastases. Medicine (Baltimore).
95:e34072016. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ahrens TD, Bang-Christensen SR, Jorgensen
AM, Løppke C, Spliid CB, Sand NT, Clausen TM, Salanti A and Agerbæk
MØ: The role of proteoglycans in cancer metastasis and circulating
tumor cell analysis. Front Cell Dev Biol. 8:7492020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Koo B, Jun E, Liu H, Kim EJ, Park YY, Lim
SB, Kim SC and Shin Y: A biocomposite-based rapid sampling assay
for circulating cell-free DNA in liquid biopsy samples from human
cancers. Sci Rep. 10:149322020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Bi F, Wang Q, Dong Q, Wang Y, Zhang L and
Zhang J: Circulating tumor DNA in colorectal cancer: opportunities
and challenges. Am J Transl Res. 12:1044–1055. 2020.PubMed/NCBI
|
|
95
|
Gai W and Sun K: Epigenetic biomarkers in
cell-free DNA and applications in liquid biopsy. Genes (Basel).
10:322019. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Oliveira KCS, Ramos IB, Silva JMC, Barra
WF, Riggins GJ, Palande V, Pinho CT, Frenkel-Morgenstern M, Santos
SEB, Assumpcao PP, et al: Current perspectives on circulating tumor
DNA, precision medicine, and personalized clinical management of
cancer. Mol Cancer Res. 18:517–528. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Cescon DW, Bratman SV, Chan SM and Siu LL:
Circulating tumor DNA and liquid biopsy in oncology. Nat Cancer.
1:276–290. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Topham JT, Renouf DJ and Schaeffer DF:
Circulating tumor DNA: toward evolving the clinical paradigm of
pancreatic ductal adenocarcinoma. Ther Adv Med Oncol.
15:175883592311576512023. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zill OA, Greene C, Sebisanovic D, Siew LM,
Leng J, Vu M, Hendifar AE, Wang Z, Atreya CE, Kelley RK, et al:
Cell-Free DNA next-generation sequencing in pancreatobiliary
carcinomas. Cancer Discov. 5:1040–1048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Li H, Di Y, Li J, Jiang Y, He H, Yao L, Gu
J, Lu J, Song J, Chen S, et al: Blood-based genomic profiling of
circulating tumor DNA from patients with advanced pancreatic cancer
and its value to guide clinical treatment. J Cancer. 11:4316–4323.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Li S, Wang L, Zhao Q, Wang Z, Lu S, Kang
Y, Jin G and Tian J: Genome-wide analysis of cell-free DNA
methylation profiling for the early diagnosis of pancreatic cancer.
Front Genet. 11:5960782020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Eissa MAL, Lerner L, Abdelfatah E, Shankar
N, Canner JK, Hasan NM, Yaghoobi V, Huang B, Kerner Z, Takaesu F,
et al: Promoter methylation of ADAMTS1 and BNC1 as potential
biomarkers for early detection of pancreatic cancer in blood. Clin
Epigenetics. 11:592019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Hu Q, Chen L, Li K, Liu R, Sun L and Han
T: Circulating tumor DNA: Current implementation issues and future
challenges for clinical utility. Clin Chem Lab Med. 62:2094–2110.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Słotwiński R and Slotwinska SM: Diagnostic
value of selected markers and apoptotic pathways for pancreatic
cancer. Cent Eur J Immunol. 41:392–403. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Wang Z: Diagnostic performance for
declined microRNA-133a in pancreatic cancer. J Cell Biochem.
121:3882–3886. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Wei J, Yang L, Wu YN and Xu J: Serum
miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human
Pancreatic Cancer. J Cancer. 11:1325–1333. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Kopcho S, McDew-White M, Naushad W, Mohan
M and Okeoma CM: SIV Infection regulates compartmentalization of
circulating blood plasma mirnas within extracellular vesicles (EVs)
and extracellular condensates (ECs) and decreases EV-Associated
miRNA-128. Viruses. 15:6222023. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Qin C, Li T, Lin C, Zhao B, Li Z, Zhao Y
and Wang W: The systematic role of pancreatic cancer exosomes:
Distant communication, liquid biopsy and future therapy. Cancer
Cell Int. 24:2642024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zou X, Wei J, Huang Z, Zhou X, Lu Z, Zhu W
and Miao Y: Identification of a six-miRNA panel in serum benefiting
pancreatic cancer diagnosis. Cancer Med. 8:2810–2822. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Zhou X, Lu Z, Wang T, Huang Z, Zhu W and
Miao Y: Plasma miRNAs in diagnosis and prognosis of pancreatic
cancer: A miRNA expression analysis. Gene. 673:181–193. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Goto T, Fujiya M, Konishi H, Sasajima J,
Fujibayashi S, Hayashi A, Utsumi T, Sato H, Iwama T, Ijiri M, et
al: An elevated expression of serum exosomal microRNA-191, −21,
−451a of pancreatic neoplasm is considered to be efficient
diagnostic marker. BMC Cancer. 18:1162018. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Pu X, Ding G, Wu M, Zhou S, Jia S and Cao
L: Elevated expression of exosomal microRNA-21 as a potential
biomarker for the early diagnosis of pancreatic cancer using a
tethered cationic lipoplex nanoparticle biochip. Oncol Lett.
19:2062–2070. 2020.PubMed/NCBI
|
|
113
|
Machida T, Tomofuji T, Maruyama T, Yoneda
T, Ekuni D, Azuma T, Miyai H, Mizuno H, Kato H, Tsutsumi K, et al:
miR-1246 and miR-4644 in salivary exosome as potential biomarkers
for pancreatobiliary tract cancer. Oncol Rep. 36:2375–2381. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Yoshizawa N, Sugimoto K, Tameda M, Inagaki
Y, Ikejiri M, Inoue H, Usui M, Ito M and Takei Y:
miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic
biomarker for pancreatic ductal adenocarcinoma. Oncol Lett.
19:2677–2684. 2020.PubMed/NCBI
|
|
115
|
Shao H, Zhang Y, Yan J, Ban X, Fan X,
Chang X, Lu Z, Wu Y, Zong L, Mo S, et al: Upregulated
MicroRNA-483-3p is an early event in pancreatic ductal
adenocarcinoma (PDAC) and as a powerful liquid biopsy biomarker in
PDAC. Onco Targets Ther. 14:2163–2175. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Wang C, Wang J, Cui W, Liu Y, Zhou H, Wang
Y, Chen X, Chen X and Wang Z: Serum Exosomal miRNA-1226 as
potential biomarker of pancreatic ductal adenocarcinoma. Onco
Targets Ther. 14:1441–1451. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Nakamura S, Sadakari Y, Ohtsuka T, Okayama
T, Nakashima Y, Gotoh Y, Saeki K, Mori Y, Nakata K, Miyasaka Y, et
al: Pancreatic juice exosomal MicroRNAs as biomarkers for detection
of pancreatic ductal adenocarcinoma. Ann Surg Oncol. 26:2104–2111.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Chen J, Yao D, Chen W, Li Z, Guo Y, Zhu F
and Hu X: Serum exosomal miR-451a acts as a candidate marker for
pancreatic cancer. Int J Biol Markers. 37:74–80. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Wang L, Wu J, Ye N, Li F, Zhan H, Chen S
and Xu J: Plasma-derived exosome MiR-19b acts as a diagnostic
marker for pancreatic cancer. Front Oncol. 11:7391112021.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Nakamura K, Zhu Z, Roy S, Jun E, Han H,
Munoz RM, Nishiwada S, Sharma G, Cridebring D, Zenhausern F, et al:
An Exosome-based transcriptomic signature for noninvasive, early
detection of patients with pancreatic ductal adenocarcinoma: A
multicenter cohort study. Gastroenterology. 163:1252–1266. e22022.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Guo S, Qin H, Liu K, Wang H, Bai S, Liu S,
Shao Z, Zhang Y, Song B, Xu X, et al: Blood small extracellular
vesicles derived miRNAs to differentiate pancreatic ductal
adenocarcinoma from chronic pancreatitis. Clin Transl Med.
11:e5202021. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Chen J, Zhang X, Zhang G, Zhu F and Liu W:
Serum-derived exosomal miR-7977 combined with miR-451a as a
potential biomarker for pancreatic ductal adenocarcinoma. BMC
Cancer. 25:2952025. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Taniguchi T, Ideno N, Araki T, Miura S,
Yamamoto M, Nakafusa T, Higashijima N, Yamamoto T, Tamura K,
Nakamura S, et al: MicroRNA-20a in extracellular vesicles derived
from duodenal fluid is a possible biomarker for pancreatic ductal
adenocarcinoma. DEN Open. 4:e3332024. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Takahashi K, Ota Y, Kogure T, Suzuki Y,
Iwamoto H, Yamakita K, Kitano Y, Fujii S, Haneda M, Patel T and Ota
T: Circulating extracellular vesicle-encapsulated HULC is a
potential biomarker for human pancreatic cancer. Cancer Sci.
111:98–111. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Kumar SR, Kimchi ET, Manjunath Y,
Gajagowni S, Stuckel AJ and Kaifi JT: Author Correction: RNA cargos
in extracellular vesicles derived from blood serum in pancreas
associated conditions. Sci Rep. 10:99812020. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Yu S, Li Y, Liao Z, Wang Z, Li Y, Qian L,
Zhao J, Zong H, Kang B, Zou WB, et al: Plasma extracellular vesicle
long RNA profiling identifies a diagnostic signature for the
detection of pancreatic ductal adenocarcinoma. Gut. 69:540–550.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Li J, Li Z, Jiang P, Peng M, Zhang X, Chen
K, Liu H, Bi H, Liu X and Li X: Circular RNA IARS (circ-IARS)
secreted by pancreatic cancer cells and located within exosomes
regulates endothelial monolayer permeability to promote tumor
metastasis. J Exp Clin Cancer Res. 37:1772018. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Hong L, Xu L, Jin L, Xu K, Tang W, Zhu Y,
Qiu X and Wang J: Exosomal circular RNA hsa_circ_0006220, and
hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic
cancer. J Clin Lab Anal. 36:e244472022. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Kitagawa T, Taniuchi K, Tsuboi M,
Sakaguchi M, Kohsaki T, Okabayashi T and Saibara T: Circulating
pancreatic cancer exosomal RNAs for detection of pancreatic cancer.
Mol Oncol. 13:212–227. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Hu J, Sheng Y, Kwak KJ, Shi J, Yu B and
Lee LJ: A signal-amplifiable biochip quantifies extracellular
vesicle-associated RNAs for early cancer detection. Nat Commun.
8:16832017. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Yang Z, LaRiviere MJ, Ko J, Till JE,
Christensen T, Yee SS, Black TA, Tien K, Lin A, Shen H, et al: A
multianalyte panel consisting of extracellular vesicle miRNAs and
mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of
pancreatic ductal adenocarcinoma. Clin Cancer Res. 26:3248–3258.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Kumar SR, Kimchi ET, Manjunath Y,
Gajagowni S, Stuckel AJ and Kaifi JT: RNA cargos in extracellular
vesicles derived from blood serum in pancreas associated
conditions. Sci Rep. 10:28002020. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Wang F, Wang C, Chen S, Wei C, Ji J, Liu
Y, Liang L, Chen Y, Li X, Zhao L, et al: Identification of
blood-derived exosomal tumor RNA signatures as noninvasive
diagnostic biomarkers for multi-cancer: A multi-phase, multi-center
study. Mol Cancer. 24:602025. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Allenson K, Castillo J, San Lucas FA,
Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ,
et al: High prevalence of mutant KRAS in circulating
exosome-derived DNA from early-stage pancreatic cancer patients.
Ann Oncol. 28:741–747. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Castillo J, Bernard V, San Lucas FA,
Allenson K, Capello M, Kim DU, Gascoyne P, Mulu FC, Stephens BM,
Huang J, et al: Surfaceome profiling enables isolation of
cancer-specific exosomal cargo in liquid biopsies from pancreatic
cancer patients. Ann Oncol. 29:223–229. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Jin H, Liu P, Wu Y, Meng X, Wu M, Han J
and Tan X: Exosomal zinc transporter ZIP4 promotes cancer growth
and is a novel diagnostic biomarker for pancreatic cancer. Cancer
Sci. 109:2946–2956. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Xiao D, Dong Z, Zhen L, Xia G, Huang X,
Wang T, Guo H, Yang B, Xu C, Wu W, et al: Combined exosomal GPC1,
CD82, and Serum CA19-9 as multiplex targets: A specific, sensitive,
and reproducible detection panel for the diagnosis of pancreatic
cancer. Mol Cancer Res. 18:300–310. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Yang KS, Im H, Hong S, Pergolini I, Del
Castillo AF, Wang R, Clardy S, Huang CH, Pille C, Ferrone S, et al:
Multiparametric plasma EV profiling facilitates diagnosis of
pancreatic malignancy. Sci Transl Med. 9:eaal32262017. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Yang J, Zhang Y, Gao X, Yuan Y, Zhao J,
Zhou S, Wang H, Wang L, Xu G, Li X, et al: Plasma-derived exosomal
ALIX as a novel biomarker for diagnosis and classification of
pancreatic cancer. Front Oncol. 11:6283462021. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Wei Q, Zhang J, Li Z, Wei L and Ren L:
Serum Exo-EphA2 as a potential diagnostic biomarker for pancreatic
cancer. Pancreas. 49:1213–1219. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Liang K, Liu F, Fan J, Sun D, Liu C, Lyon
CJ, Bernard DW, Li Y, Yokoi K, Katz MH, et al: Nanoplasmonic
quantification of tumor-derived extracellular vesicles in plasma
microsamples for diagnosis and treatment monitoring. Nat Biomed
Eng. 1:002112017 View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Shin HS, Jung SB, Park S, Dua P and Lee
DK: ALPPL2 Is a potential diagnostic biomarker for pancreatic
cancer-derived extracellular vesicles. Mol Ther Methods Clin Dev.
15:204–210. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Lux A, Kahlert C, Grutzmann R and Pilarsky
C: c-Met and PD-L1 on circulating exosomes as diagnostic and
prognostic markers for pancreatic cancer. Int J Mol Sci.
20:33052019. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
David P, Kouhestani D, Hansen FJ, Paul S,
Czubayko F, Karabiber A, Weisel N, Klösch B, Merkel S, Ole-Baur J,
et al: Exosomal CD40, CD25, and Serum CA19-9 as combinatory novel
liquid biopsy biomarker for the diagnosis and prognosis of patients
with pancreatic ductal adenocarcinoma. Int J Mol Sci. 26:15002025.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Fan Z, Yu J, Lin J, Liu Y and Liao Y:
Exosome-specific tumor diagnosis via biomedical analysis of
exosome-containing microRNA biomarkers. Analyst. 144:5856–5865.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Long Y, Wang X, Youmans DT and Cech TR:
How do lncRNAs regulate transcription? Sci Adv. 3:eaao21102017.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Pandya G, Kirtonia A, Sethi G, Pandey AK
and Garg M: The implication of long non-coding RNAs in the
diagnosis, pathogenesis and drug resistance of pancreatic ductal
adenocarcinoma and their possible therapeutic potential. Biochim
Biophys Acta Rev Cancer. 1874:1884232020. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Lin H, Yu J, Gu X, Ge S and Fan X: Novel
insights into exosomal circular RNAs: Redefining intercellular
communication in cancer biology. Clin Transl Med. 11:e6362021.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Chen Q and Zhou T: Emerging functional
principles of tRNA-derived small RNAs and other regulatory small
RNAs. J Biol Chem. 299:1052252023. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Guo S, Wang X, Shan D, Xiao Y, Ju L, Zhang
Y, Wang G and Qian K: The detection, biological function, and
liquid biopsy application of extracellular vesicle-associated DNA.
Biomark Res. 12:1232024. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Makler A and Narayanan R: Mining exosomal
genes for pancreatic cancer targets. Cancer Genomics Proteomics.
14:161–172. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Li H, Chiang CL, Kwak KJ, Wang X, Doddi S,
Ramanathan LV, Cho SM, Hou YC, Cheng TS, Mo X, et al: Extracellular
vesicular analysis of glypican 1 mRNA and protein for pancreatic
cancer diagnosis and prognosis. Adv Sci (Weinh). 11:e23063732024.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Buscail E, Chauvet A, Quincy P, Degrandi
O, Buscail C, Lamrissi I, Moranvillier I, Caumont C, Verdon S,
Brisson A, et al: CD63-GPC1-positive exosomes coupled with CA19-9
offer good diagnostic potential for resectable pancreatic ductal
adenocarcinoma. Transl Oncol. 12:1395–1403. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Lai X, Wang M, McElyea SD, Sherman S,
House M and Korc M: A microRNA signature in circulating exosomes is
superior to exosomal glypican-1 levels for diagnosing pancreatic
cancer. Cancer Lett. 393:86–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Skotland T, Hessvik NP, Sandvig K and
Llorente A: Exosomal lipid composition and the role of ether lipids
and phosphoinositides in exosome biology. J Lipid Res. 60:9–18.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Sharma R, Huang X, Brekken RA and Schroit
AJ: Detection of phosphatidylserine-positive exosomes for the
diagnosis of early-stage malignancies. Br J Cancer. 117:545–552.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Tao L, Zhou J, Yuan C, Zhang L, Li D, Si
D, Xiu D and Zhong L: Metabolomics identifies serum and exosomes
metabolite markers of pancreatic cancer. Metabolomics. 15:862019.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Tiankanon K, Pungpipattrakul N, Sukaram T,
Chaiteerakij R and Rerknimitr R: Identification of breath volatile
organic compounds to distinguish pancreatic adenocarcinoma,
pancreatic cystic neoplasm, and patients without pancreatic
lesions. World J Gastrointest Oncol. 16:894–906. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Pelling M, Chandrapalan S, West E and
Arasaradnam RP: A systematic review and meta-analysis: Volatile
organic compound analysis in the detection of hepatobiliary and
pancreatic cancers. Cancers (Basel). 15:23082023. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Nagarajan Y, Chandrasekaran N and Deepa
Parvathi V: Functionalized nanomaterials in pancreatic cancer
theranostics and molecular imaging. ChemistryOpen.
14:e2024002322025. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Caputo D and Caracciolo G:
Nanoparticle-enabled blood tests for early detection of pancreatic
ductal adenocarcinoma. Cancer Lett. 470:191–196. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Yin X, He Z, Ge W and Zhao Z: Application
of aptamer functionalized nanomaterials in targeting therapeutics
of typical tumors. Front Bioeng Biotechnol. 11:10929012023.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Moccia M, Caratelli V, Cinti S, Pede B,
Avitabile C, Saviano M, Imbriani AL, Moscone D and Arduini F:
Paper-based electrochemical peptide nucleic acid (PNA) biosensor
for detection of miRNA-492: A pancreatic ductal adenocarcinoma
biomarker. Biosens Bioelectron. 165:1123712020. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Carigga Gutierrez NM, Clainche TL, Bulin
AL, Leo S, Kadri M, Abdelhamid AGA, Pujol-Solé N, Obaid G,
Hograindleur MA, Gardette V, et al: Engineering radiocatalytic
nanoliposomes with hydrophobic gold nanoclusters for radiotherapy
enhancement. Adv Mater. 36:e24046052024. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Phua VJX, Yang CT, Xia B, Yan SX, Liu J,
Aw SE, He T and Ng DCE: Nanomaterial probes for nuclear imaging.
Nanomaterials (Basel). 12:5822022. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Kaczor-Urbanowicz KE, Cheng J, King JC,
Sedarat A, Pandol SJ, Farrell JJ, Wong DTW and Kim Y: Reviews on
current liquid biopsy for detection and management of pancreatic
cancers. Pancreas. 49:1141–1152. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Qiao Z, Ge J, He W, Xu X and He J:
Artificial intelligence algorithm-based computerized tomography
image features combined with serum tumor markers for diagnosis of
pancreatic cancer. Comput Math Methods Med. 2022:89794042022.
View Article : Google Scholar : PubMed/NCBI
|
